Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
This p53-target gene encodes a brain-specific angiogenesis inhibitor, a seven-span transmembrane protein, and is thought to be a member of the secretin receptor family. Zusätzlich bieten wir Ihnen BAI3 Antikörper (69) und BAI3 Proteine (12) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 18 products:
BAI3 mediates the inhibitory effects of C1ql3 on insulin secretion from pancreatic beta-cells.
BAI3 has the potential to act as target for pharmaceutical intervention inline with developing trends in molecular pathology aiming to provide personalized, treatment regimes based on tumor-specific mutation profiles.
Discriminated small-cell lung carcinoma from large-cell neuroendocrine lung carcinoma with immunohistochemical markers BAI3, CDX2 and VIL1.
The BAI3 locus where the rs9363864 maps is a new candidate for venous thromboembolism risk
C1ql proteins are secreted signaling molecules that bind to BAI3 and act, at least in part, to regulate synapse formation and/or maintenance.
Level of disorganized symptoms was significantly (P < 6.00 x 10(-5)) associated 2 SNPs within the brain-specific angiogenesis inhibitor 3 (BAI3) gene, which is highly expressed in brain during development.
The secreted complement component 1, q subcomponent-like protein 4 (C1qL4) repress myoblast fusion by specifically interacting with G protein-coupled receptor BAI3 (BAI3). Stabilin-2 interacts with BAI3 and stimulates its fusion promoting activity. The resulting activated heterotrimeric G-proteins contribute to the initial recruitment of Elmo proteins to the membrane, which are then stabilized on BAI3.
Signal transduction via C1qL1-BAI3 interaction is required for motor learning, triggers pruting of surplus cerebellar climbing fibers, and is required to maintain climbing fiber synapses.
G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates.
results reveal that the BAI3 receptor controls dendritic arborization growth and branching in cultured neurons.
Two transcripts with significant regulation from days 7 to 28 in the 1-methyl-4-phenyl-tetrahydropyridine treated groups are identified: brain specific angiogenesis inhibitor associated protein 3 (Baiap3) and breast carcinoma amplified sequence 1 (Bcas1).
This p53-target gene encodes a brain-specific angiogenesis inhibitor, a seven-span transmembrane protein, and is thought to be a member of the secretin receptor family. Brain-specific angiogenesis proteins BAI2 and BAI3 are similar to BAI1 in structure, have similar tissue specificities, and may also play a role in angiogenesis.
dJ91B17.1 (brain-specific angiogenesis inhibitor 3)
, BAI3, brain-specific angiogenesis inhibitor 3
, brain-specific angiogenesis inhibitor 3
, brain-specific angiogenesis inhibitor 3-like
, G protein-coupled receptor BAI3